A Bespoke Solution for Your Clinical Trial & Supplies Management
AvanSource is a comparator sourcing specialist exclusively dedicated to providing clients with high-quality comparators sourced from the European Union.
Our mission is to empower pharmaceutical and biotech companies to accelerate their clinical trials and bring life-changing advanced therapies to market faster.
Our expert team, strategic partnerships, and innovative smart clinical supplies management based on data-driven analysis ensure access to high-quality comparators, enabling clients to reduce the complexity of a clinical trial and mitigate risks related to comparator procurement.
As a boutique clinical supplies company, we prioritize each client's unique needs, offering customized sourcing strategies and unparalleled support throughout the clinical trial supply process.
Our in-depth knowledge of the comparator landscape ensures accurate identification and procurement of high-quality comparators, fostering successful clinical trials.
AvanSource's nimble approach allows us to adapt quickly to changing market conditions, regulatory requirements, and client needs, ensuring optimal sourcing outcomes.
We maintain strong relationships with a network of reliable suppliers, enabling access to a diverse range of comparators while adhering to the highest quality standards.
From procurement and quality assurance to logistics and risk management, AvanSource offers end-to-end comparator sourcing solutions that streamline the clinical trial process.
By focusing exclusively on Clinical Trial Supplies, AvanSource provides solutions that empower clients to navigate the complexities of clinical supply procurement with confidence and efficiency.
In the realm of clinical trial logistics, particularly within the specialized and high-stakes field of immune-oncology, supplying comparator drugs is a complex process that demands strategic foresight and precision. Comparator products are used in trials to benchmark the performance of investigational medicines, making their accurate sourcing crucial to the validity
A US-based clinical-stage biotechnology company, actively engaged in the development of next-generation immuno-oncology therapies, was preparing for a multisite Phase 3 interventional clinical trial across several European Union member states. The trial involved a therapeutic regimen where a PD-1 immune checkpoint inhibitor widely used in oncology was utilized as a
To learn more about AvanSource and how our experienced leadership team can support your clinical trial success, please don’t hesitate to contact us. We look forward to working together and demonstrating the AvanSource difference.
AvanSource © All rights reserved.AvanSource a.s., Prievozská 4D, Blok E, 821 09 Bratislava SR | Web by Nimble.help | Graphic design: Gabriela Holcer
